Elevated B cell activation is associated with type 2 diabetes development in obese subjects

Cellular Physiology and Biochemistry

Volumn 38, Issue 3, 2016, Pages 1257-1266

  Zhai, Xiao ^a   Qian, Guangfang ^b   Wang, Yiran ^a   Chen, Xiao ^a   Lu, Jiancan ^a   Zhang, Yaping ^a   Huang, Qin ^a   Wang, Qijin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Endocrinology   (China)

Author keywords

B cell; Obesity; Type 2 diabetes

Indexed keywords

B LYMPHOCYTE ANTIBODY; GLUCOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MEMORY CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMABLAST; PLEIOTROPY; PRIORITY JOURNAL; SEASONAL INFLUENZA; ADAPTIVE IMMUNITY; B LYMPHOCYTE; COMPLICATION; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADAPTIVE IMMUNITY; ANTIBODY FORMATION; B-LYMPHOCYTES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OBESITY;

EID: 84962575695     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000443073     Document Type: Article

References (23)

1. Smyth S, Heron A: Diabetes and obesity: the twin epidemics. Nat Med 2006;12:75-80.
2. Leahy JL: Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005;36:197-209.
3. Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011;11:98-107.
4. Manna P, Jain SK: Phosphatidylinositol-3,4,5-Triphosphate and cellular signaling: implications for obesity and diabetes. Cell Physiol Biochem 2015;35:1253-75.
5. Donath MY: Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov 2014;13:465-476.
6. Busque SM, Stange G, Wagner CA: Dysregulation of the glutamine transporter Slc38a3 (SNAT3) and ammoniagenic enzymes in obese, glucose-intolerant mice. Cell Physiol Biochem 2014;34:575-89.
7. Gregor MF, Hotamisligil GS: Inflammatory mechanisms in obesity. Annu Rev Immunol 2011;29:415-445.
8. Shoelson SE, Herrero L, Naaz A: Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169-2180.
9. DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, Markham D, Strissel KJ, Watkins AA, Zhu M, Allen J, Bouchard J, Toraldo G, Jasuja R, Obin MS, McDonnell ME, Apovian C, Denis GV, Nikolajczyk BS: B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA 2013;110:5133-5138.
10. Jagannathan M, McDonnell M, Liang Y, Hasturk H, Hetzel J, Rubin D, Kantarci A, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS: Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010;53:1461-1471.
11. Bordon Y: B cell responses: Plasmablasts walk the line. Nat Rev Immunol 2010;10:541.
12. Fink K: Origin and Function of Circulating Plasmablasts during Acute Viral Infections. Front Immunol 2012;3:78.
13. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S: The pro-And anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011;1813:878-888.
14. Lund FE: Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008;20:332-338.
15. Mauri C, Bosma A: Immune regulatory function of B cells. Annu Rev Immunol 2012;30:221-241.
16. Reder S, Riffelmann M, Becker C, von Konig CHW: Measuring immunoglobulin G antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-Antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay. Clin Vaccine Immunol 2008;15:744-749.
17. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD, Hall RP, St Clair EW, Tedder TF: Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011;117:530-541.
18. Pillai S, Mattoo H, Cariappa A: B cells and autoimmunity. Curr Opin Immunol 2011;23:721-731.
19. Tan EM: Autoantibodies, autoimmune disease, and the birth of immune diagnostics. J Clin Invest 2012;122:3835-3836.
20. Crotty S: T follicular helper cell differentiation, function, and roles in disease. Immunity 2014;41:529-542.
21. Montes CL, Acosta-Rodriguez EV, Merino MC, Bermejo DA, Gruppi A: Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host?. J Leukoc Biol 2007;82:1027-1032.
22. Moir S, Fauci AS: Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals. Immunol Rev 2013;254:207-224.
23. Frasca D, Diaz A, Romero M, Mendez NV, Landin AM, Ryan JG, Blomberg BB.: Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013;31:3603-3610.